O	O	0	11	Involvement	Involvement	B-NP	NN	O	0	ROOT	O
O	O	12	14	of	of	B-PP	IN	O	1	NMOD	O
O	O	15	16	a	a	B-NP	DT	O	4	NMOD	O
O	O	17	23	second	second	I-NP	JJ	O	2	PMOD	O
T3	B-Entity	24	32	lymphoid	lymphoid	I-NP	JJ	B-DNA	9	NMOD	B-DNA
T3	I-Entity	32	33	-	-	I-NP	HYPH	I-DNA	9	NMOD	I-DNA
T3	I-Entity	33	41	specific	specific	I-NP	JJ	I-DNA	9	NMOD	I-DNA
T3	I-Entity	42	50	enhancer	enhancer	I-NP	NN	I-DNA	9	NMOD	I-DNA
T3	I-Entity	51	58	element	element	I-NP	NN	I-DNA	4	NMOD	I-DNA
O	O	59	61	in	in	B-PP	IN	O	1	NMOD	O
O	O	62	65	the	the	B-NP	DT	O	12	NMOD	O
O	O	66	76	regulation	regulation	I-NP	NN	O	10	PMOD	O
O	O	77	79	of	of	B-PP	IN	O	12	NMOD	O
T4	B-Entity	80	94	immunoglobulin	immunoglobulin	B-NP	NN	B-DNA	19	NMOD	B-DNA
T4	I-Entity	95	100	heavy	heavy	I-NP	JJ	I-DNA	19	NMOD	I-DNA
T4	I-Entity	100	101	-	-	I-NP	HYPH	I-DNA	19	NMOD	I-DNA
T4	I-Entity	101	106	chain	chain	I-NP	NN	I-DNA	19	NMOD	I-DNA
T4	I-Entity	107	111	gene	gene	I-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	112	122	expression	expression	I-NP	NN	O	13	PMOD	O
O	O	122	123	.	.	O	.	O	1	P	O

O	O	125	127	To	To	B-VP	TO	O	2	VMOD	O
O	O	128	137	determine	determine	I-VP	VB	O	38	VMOD	O
O	O	138	145	whether	whether	B-SBAR	IN	O	2	VMOD	O
T5	B-Entity	146	154	enhancer	enhancer	B-NP	NN	B-DNA	5	NMOD	B-DNA
T5	I-Entity	155	163	elements	element	I-NP	NNS	I-DNA	19	SUB	I-DNA
O	O	164	166	in	in	B-PP	IN	O	5	NMOD	O
O	O	167	175	addition	addition	B-NP	NN	O	6	PMOD	O
O	O	176	178	to	to	B-PP	TO	O	7	NMOD	O
O	O	179	182	the	the	B-NP	DT	O	10	NMOD	O
O	O	183	189	highly	highly	I-NP	RB	O	8	PMOD	O
O	O	190	199	conserved	conserve	I-NP	VBN	O	10	NMOD	O
T6	B-Entity	200	207	octamer	octamer	I-NP	NN	B-DNA	10	NMOD	B-DNA
T6	I-Entity	208	209	(	(	O	(	I-DNA	15	DEP	I-DNA
T6	I-Entity	209	213	OCTA	OCTA	B-NP	NN	I-DNA	15	DEP	I-DNA
T6	I-Entity	213	214	)	)	O	)	I-DNA	12	NMOD	I-DNA
T6	I-Entity	214	215	-	-	B-NP	HYPH	I-DNA	18	NMOD	I-DNA
T6	I-Entity	215	225	nucleotide	nucleotide	I-NP	NN	I-DNA	18	NMOD	I-DNA
T6	I-Entity	226	231	motif	motif	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	232	235	are	be	B-VP	VBP	O	3	SBAR	O
O	O	236	245	important	important	B-ADJP	JJ	O	19	PRD	O
O	O	246	249	for	for	B-PP	IN	O	20	AMOD	O
O	O	250	258	lymphoid	lymphoid	B-NP	JJ	O	25	NMOD	O
O	O	258	259	-	-	I-NP	HYPH	O	25	NMOD	O
O	O	259	267	specific	specific	I-NP	JJ	O	25	NMOD	O
O	O	268	278	expression	expression	I-NP	NN	O	21	PMOD	O
O	O	279	281	of	of	B-PP	IN	O	25	NMOD	O
O	O	282	285	the	the	B-NP	DT	O	35	NMOD	O
T7	B-Entity	286	300	immunoglobulin	immunoglobulin	I-NP	NN	B-DNA	35	NMOD	B-DNA
T7	I-Entity	301	306	heavy	heavy	B-ADJP	JJ	I-DNA	35	NMOD	I-DNA
T7	I-Entity	306	307	-	-	O	HYPH	I-DNA	35	NMOD	I-DNA
T7	I-Entity	307	312	chain	chain	B-NP	NN	I-DNA	35	NMOD	I-DNA
T7	I-Entity	313	314	(	(	O	(	I-DNA	35	NMOD	I-DNA
T7	I-Entity	314	317	IgH	IgH	B-NP	NN	I-DNA	35	NMOD	I-DNA
T7	I-Entity	317	318	)	)	O	)	I-DNA	35	NMOD	I-DNA
T7	I-Entity	319	323	gene	gene	B-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	323	324	,	,	O	,	O	38	P	O
O	O	325	327	we	we	B-NP	PRP	O	38	SUB	O
O	O	328	332	have	have	B-VP	VBP	O	0	ROOT	O
O	O	333	345	investigated	investigate	I-VP	VBN	O	38	VC	O
O	O	346	349	the	the	B-NP	DT	O	41	NMOD	O
O	O	350	356	effect	effect	I-NP	NN	O	39	OBJ	O
O	O	357	359	of	of	B-PP	IN	O	41	NMOD	O
O	O	360	368	mutating	mutate	B-VP	VBG	O	42	PMOD	O
O	O	369	372	the	the	B-NP	DT	O	46	NMOD	O
T8	B-Entity	373	380	binding	bind	I-NP	VBG	B-DNA	46	NMOD	B-DNA
T8	I-Entity	381	385	site	site	I-NP	NN	I-DNA	43	OBJ	I-DNA
O	O	386	389	for	for	B-PP	IN	O	46	NMOD	O
O	O	390	391	a	a	B-NP	DT	O	55	NMOD	O
O	O	392	400	putative	putative	I-NP	JJ	O	55	NMOD	O
O	O	401	411	additional	additional	I-NP	JJ	O	55	NMOD	O
O	O	412	420	lymphoid	lymphoid	I-NP	JJ	O	55	NMOD	O
O	O	420	421	-	-	I-NP	HYPH	O	51	P	O
O	O	421	429	specific	specific	I-NP	JJ	O	51	AMOD	O
O	O	430	443	transcription	transcription	I-NP	NN	B-protein	55	NMOD	B-protein
O	O	444	450	factor	factor	I-NP	NN	I-protein	47	PMOD	I-protein
O	O	450	451	,	,	O	,	O	55	P	O
O	O	452	462	designated	designate	B-NP	VBN	O	55	NMOD	O
T1	B-Protein	463	465	NF	NF	I-NP	NN	B-protein	60	NMOD	B-protein
T1	I-Protein	465	466	-	-	O	HYPH	I-protein	60	P	I-protein
T1	I-Protein	466	472	microB	microB	B-NP	NN	I-protein	57	VMOD	I-protein
O	O	472	473	,	,	O	,	O	46	P	O
O	O	474	476	in	in	B-PP	IN	O	46	NMOD	O
O	O	477	480	the	the	B-NP	DT	O	66	NMOD	O
T9	B-Entity	481	487	murine	murine	I-NP	JJ	B-DNA	66	NMOD	B-DNA
T9	I-Entity	488	491	IgH	IgH	I-NP	NN	I-DNA	66	NMOD	I-DNA
T9	I-Entity	492	500	enhancer	enhancer	I-NP	NN	I-DNA	62	PMOD	I-DNA
O	O	500	501	.	.	O	.	O	38	P	O

O	O	502	504	We	We	B-NP	PRP	O	2	SUB	O
O	O	505	516	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	517	521	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	522	525	the	the	B-NP	DT	O	7	NMOD	O
T2	B-Protein	526	528	NF	NF	I-NP	NN	B-protein	7	NMOD	B-protein
T2	I-Protein	528	529	-	-	B-NP	HYPH	I-protein	7	P	I-protein
T2	I-Protein	529	535	microB	microB	I-NP	NN	I-protein	10	NMOD	I-protein
T10	B-Entity	535	536	-	-	B-PP	HYPH	O	10	NMOD	O
T10	I-Entity	536	543	binding	bind	B-NP	VBG	B-DNA	10	NMOD	B-DNA
T10	I-Entity	544	548	site	site	I-NP	NN	I-DNA	11	SUB	I-DNA
O	O	549	554	plays	play	B-VP	VBZ	O	3	SBAR	O
O	O	555	556	a	a	B-NP	DT	O	14	NMOD	O
O	O	557	565	critical	critical	I-NP	JJ	O	14	NMOD	O
O	O	566	570	role	role	I-NP	NN	O	11	OBJ	O
O	O	571	573	in	in	B-PP	IN	O	11	VMOD	O
O	O	574	577	the	the	B-NP	DT	O	18	NMOD	O
T11	B-Entity	578	581	IgH	IgH	I-NP	NN	B-DNA	18	NMOD	B-DNA
T11	I-Entity	582	590	enhancer	enhancer	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	590	591	,	,	O	,	O	11	P	O
O	O	592	599	because	because	B-SBAR	IN	O	11	VMOD	O
O	O	600	608	mutation	mutation	B-NP	NN	O	27	SUB	O
O	O	609	611	of	of	B-PP	IN	O	21	NMOD	O
O	O	612	615	the	the	B-NP	DT	O	26	NMOD	O
T12	B-Entity	616	622	microB	microB	I-NP	NN	B-DNA	26	NMOD	B-DNA
T12	I-Entity	623	626	DNA	DNA	I-NP	NN	I-DNA	26	NMOD	I-DNA
T12	I-Entity	627	632	motif	motif	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	633	642	decreased	decrease	B-VP	VBD	O	20	SBAR	O
O	O	643	658	transcriptional	transcriptional	B-NP	JJ	O	29	NMOD	O
O	O	659	667	activity	activity	I-NP	NN	O	27	OBJ	O
O	O	668	670	of	of	B-PP	IN	O	29	NMOD	O
O	O	671	674	the	the	B-NP	DT	O	33	NMOD	O
T13	B-Entity	675	678	IgH	IgH	I-NP	NN	B-DNA	33	NMOD	B-DNA
T13	I-Entity	679	687	enhancer	enhancer	I-NP	NN	I-DNA	30	PMOD	I-DNA
O	O	688	690	in	in	B-PP	IN	O	27	VMOD	O
O	O	691	696	cells	cell	B-NP	NNS	O	34	PMOD	O
O	O	697	699	of	of	B-PP	IN	O	35	NMOD	O
O	O	700	703	the	the	B-NP	DT	O	41	NMOD	O
O	O	704	705	B	B	I-NP	NN	B-cell_type	41	NMOD	B-cell_type
O	O	705	706	-	-	B-NP	HYPH	I-cell_type	41	NMOD	I-cell_type
O	O	706	710	cell	cell	I-NP	NN	I-cell_type	41	NMOD	I-cell_type
O	O	711	718	lineage	lineage	I-NP	NN	I-cell_type	36	PMOD	I-cell_type
O	O	719	722	but	but	B-PP	CC	O	34	PMOD	O
O	O	723	726	not	not	B-PP	RB	O	44	PMOD	O
O	O	727	729	in	in	I-PP	IN	O	34	PMOD	O
O	O	730	741	nonlymphoid	nonlymphoid	B-NP	JJ	B-cell_type	46	NMOD	B-cell_type
O	O	742	747	cells	cell	I-NP	NNS	I-cell_type	44	PMOD	I-cell_type
O	O	747	748	.	.	O	.	O	2	P	O

O	O	749	753	This	This	B-NP	DT	O	2	NMOD	O
O	O	754	760	effect	effect	I-NP	NN	O	3	SUB	O
O	O	761	764	was	be	B-VP	VBD	O	0	ROOT	O
O	O	765	775	comparable	comparable	B-ADJP	JJ	O	8	AMOD	O
O	O	776	778	to	to	B-PP	TO	O	4	AMOD	O
O	O	779	781	or	or	O	CC	O	8	AMOD	O
O	O	782	786	even	even	B-ADJP	RB	O	8	AMOD	O
O	O	787	795	stronger	strong	I-ADJP	JJR	O	3	PRD	O
O	O	796	800	than	than	B-PP	IN	O	8	AMOD	O
O	O	801	804	the	the	B-NP	DT	O	11	NMOD	O
O	O	805	811	effect	effect	I-NP	NN	O	8	AMOD	O
O	O	812	814	of	of	B-PP	IN	O	11	NMOD	O
O	O	815	816	a	a	B-NP	DT	O	14	NMOD	O
O	O	817	825	mutation	mutation	I-NP	NN	O	12	PMOD	O
O	O	826	828	in	in	B-PP	IN	O	14	NMOD	O
O	O	829	832	the	the	B-NP	DT	O	18	NMOD	O
T14	B-Entity	833	837	OCTA	OCTA	I-NP	NN	B-DNA	18	NMOD	B-DNA
T14	I-Entity	838	842	site	site	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	842	843	.	.	O	.	O	3	P	O

O	O	844	852	Moreover	Moreover	B-ADVP	RB	O	12	VMOD	O
O	O	852	853	,	,	O	,	O	12	P	O
O	O	854	862	combined	combine	B-NP	VBN	O	4	NMOD	O
O	O	863	871	mutation	mutation	I-NP	NN	O	12	SUB	O
O	O	872	874	of	of	B-PP	IN	O	4	NMOD	O
O	O	875	879	both	both	O	CC	O	10	NMOD	O
O	O	880	886	microB	microB	B-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	887	890	and	and	O	CC	O	10	NMOD	O
O	O	891	895	OCTA	OCTA	B-NP	NN	B-DNA	10	NMOD	B-DNA
T15	B-Entity	896	901	sites	site	I-NP	NNS	I-DNA	5	PMOD	I-DNA
O	O	902	909	further	further	B-ADVP	RBR	O	12	VMOD	O
O	O	910	917	reduced	reduce	B-VP	VBD	O	0	ROOT	O
O	O	918	926	enhancer	enhancer	B-NP	NN	O	14	NMOD	O
O	O	927	935	activity	activity	I-NP	NN	O	12	OBJ	O
O	O	936	938	in	in	B-PP	IN	O	14	NMOD	O
O	O	939	947	lymphoid	lymphoid	B-NP	JJ	B-cell_type	17	NMOD	B-cell_type
O	O	948	953	cells	cell	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	953	954	.	.	O	.	O	12	P	O

O	O	955	968	Interestingly	Interestingly	B-ADVP	RB	O	30	VMOD	O
O	O	968	969	,	,	O	,	O	30	P	O
O	O	970	980	alteration	alteration	B-NP	NN	O	30	SUB	O
O	O	981	983	of	of	B-PP	IN	O	3	NMOD	O
O	O	984	990	either	either	O	CC	O	10	NMOD	O
O	O	991	994	the	the	B-NP	DT	O	10	NMOD	O
O	O	995	1001	microB	microB	I-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	1002	1004	or	or	I-NP	CC	O	10	NMOD	O
O	O	1005	1007	E3	E3	I-NP	NN	B-DNA	10	NMOD	B-DNA
T16	B-Entity	1008	1012	site	site	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	1013	1015	in	in	B-PP	IN	O	3	NMOD	O
O	O	1016	1017	a	a	B-NP	DT	O	18	NMOD	O
T17	B-Entity	1018	1020	70	70	I-NP	CD	B-DNA	18	NMOD	B-DNA
T17	I-Entity	1020	1021	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
T17	I-Entity	1021	1025	base	base	I-NP	NN	I-DNA	18	NMOD	I-DNA
T17	I-Entity	1025	1026	-	-	I-NP	HYPH	I-DNA	18	NMOD	I-DNA
T17	I-Entity	1026	1030	pair	pair	I-NP	NN	I-DNA	18	NMOD	I-DNA
T17	I-Entity	1031	1039	fragment	fragment	I-NP	NN	I-DNA	11	PMOD	I-DNA
O	O	1040	1042	of	of	B-PP	IN	O	18	NMOD	O
O	O	1043	1046	the	the	B-NP	DT	O	22	NMOD	O
T18	B-Entity	1047	1050	IgH	IgH	I-NP	NN	B-DNA	22	NMOD	B-DNA
T18	I-Entity	1051	1059	enhancer	enhancer	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	1060	1064	that	that	B-NP	WDT	O	22	NMOD	O
O	O	1065	1070	lacks	lack	B-VP	VBZ	O	23	SBAR	O
O	O	1071	1074	the	the	B-NP	DT	O	27	NMOD	O
T19	B-Entity	1075	1082	binding	bind	I-NP	VBG	B-DNA	27	NMOD	B-DNA
T19	I-Entity	1083	1087	site	site	I-NP	NN	I-DNA	24	OBJ	I-DNA
T19	I-Entity	1088	1091	for	for	B-PP	IN	O	27	NMOD	O
T19,T20	I-Entity,B-Entity	1092	1096	OCTA	OCTA	B-NP	NN	B-protein	28	PMOD	B-protein
O	O	1097	1106	abolished	abolish	B-VP	VBD	O	0	ROOT	O
O	O	1107	1115	enhancer	enhancer	B-NP	NN	O	32	NMOD	O
O	O	1116	1124	activity	activity	I-NP	NN	O	30	OBJ	O
O	O	1125	1127	in	in	B-PP	IN	O	32	NMOD	O
O	O	1128	1136	lymphoid	lymphoid	B-NP	JJ	B-cell_type	35	NMOD	B-cell_type
O	O	1137	1142	cells	cell	I-NP	NNS	I-cell_type	33	PMOD	I-cell_type
O	O	1143	1153	completely	completely	B-ADVP	RB	O	30	VMOD	O
O	O	1153	1154	.	.	O	.	O	30	P	O

O	O	1155	1167	Nevertheless	Nevertheless	B-ADVP	RB	O	10	VMOD	O
O	O	1167	1168	,	,	O	,	O	10	P	O
O	O	1169	1170	a	a	B-NP	DT	O	4	NMOD	O
O	O	1171	1179	multimer	multimer	I-NP	NN	O	10	SUB	O
O	O	1180	1182	of	of	B-PP	IN	O	4	NMOD	O
O	O	1183	1186	the	the	B-NP	DT	O	8	NMOD	O
T21	B-Entity	1187	1193	microB	microB	I-NP	NN	B-DNA	8	NMOD	B-DNA
T21	I-Entity	1194	1199	motif	motif	I-NP	NN	I-DNA	5	PMOD	I-DNA
O	O	1200	1205	alone	alone	B-ADVP	RB	O	4	NMOD	O
O	O	1206	1212	showed	show	B-VP	VBD	O	0	ROOT	O
O	O	1213	1215	no	no	B-NP	DT	O	13	NMOD	O
O	O	1216	1224	enhancer	enhancer	I-NP	NN	O	13	NMOD	O
O	O	1225	1233	activity	activity	I-NP	NN	O	10	OBJ	O
O	O	1233	1234	.	.	O	.	O	10	P	O

O	O	1235	1240	DNase	DNase	B-NP	NN	B-protein	3	NMOD	B-protein
O	O	1241	1253	footprinting	footprinting	I-NP	NN	O	3	NMOD	O
O	O	1254	1262	analysis	analysis	I-NP	NN	O	4	SUB	O
O	O	1263	1275	corroborated	corroborate	B-VP	VBD	O	0	ROOT	O
O	O	1276	1279	the	the	B-NP	DT	O	7	NMOD	O
O	O	1280	1290	functional	functional	I-NP	JJ	O	7	NMOD	O
O	O	1291	1295	data	datum	I-NP	NNS	O	4	OBJ	O
O	O	1296	1303	showing	show	B-VP	VBG	O	7	NMOD	O
O	O	1304	1308	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	1309	1310	a	a	B-NP	DT	O	14	NMOD	O
O	O	1311	1319	lymphoid	lymphoid	I-NP	JJ	B-protein	14	NMOD	B-protein
O	O	1319	1320	-	-	I-NP	HYPH	I-protein	14	NMOD	I-protein
O	O	1320	1328	specific	specific	I-NP	JJ	I-protein	14	NMOD	I-protein
O	O	1329	1336	protein	protein	I-NP	NN	I-protein	15	SUB	I-protein
O	O	1337	1342	binds	bind	B-VP	VBZ	O	9	SBAR	O
O	O	1343	1345	to	to	B-PP	TO	O	15	VMOD	O
O	O	1346	1349	the	the	B-NP	DT	O	20	NMOD	O
T22	B-Entity	1350	1356	microB	microB	I-NP	NN	B-DNA	20	NMOD	B-DNA
T22	I-Entity	1357	1360	DNA	DNA	I-NP	NN	I-DNA	20	NMOD	I-DNA
T22	I-Entity	1361	1366	motif	motif	I-NP	NN	I-DNA	16	PMOD	I-DNA
O	O	1366	1367	.	.	O	.	O	4	P	O

O	O	1368	1371	Our	Our	B-NP	PRP$	O	2	NMOD	O
O	O	1372	1379	results	result	I-NP	NNS	O	3	SUB	O
O	O	1380	1387	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1388	1392	that	that	B-SBAR	IN	O	24	DEP	O
O	O	1393	1396	the	the	B-NP	DT	O	7	NMOD	O
T23	B-Entity	1397	1403	microB	microB	I-NP	NN	B-DNA	7	NMOD	B-DNA
T23	I-Entity	1404	1411	element	element	I-NP	NN	I-DNA	8	SUB	I-DNA
O	O	1412	1414	is	be	B-VP	VBZ	O	4	SBAR	O
O	O	1415	1416	a	a	B-NP	DT	O	12	NMOD	O
O	O	1417	1420	new	new	I-NP	JJ	O	11	AMOD	O
O	O	1421	1428	crucial	crucial	I-NP	JJ	O	12	NMOD	O
O	O	1429	1436	element	element	I-NP	NN	O	8	PRD	O
O	O	1437	1446	important	important	B-ADJP	JJ	O	12	NMOD	O
O	O	1447	1450	for	for	B-PP	IN	O	13	AMOD	O
O	O	1451	1459	lymphoid	lymphoid	B-NP	JJ	O	18	NMOD	O
O	O	1459	1460	-	-	I-NP	HYPH	O	18	NMOD	O
O	O	1460	1468	specific	specific	I-NP	JJ	O	18	NMOD	O
O	O	1469	1479	expression	expression	I-NP	NN	O	14	PMOD	O
O	O	1480	1482	of	of	B-PP	IN	O	18	NMOD	O
O	O	1483	1486	the	the	B-NP	DT	O	22	NMOD	O
T24	B-Entity	1487	1490	IgH	IgH	I-NP	NN	B-DNA	22	NMOD	B-DNA
T24	I-Entity	1491	1495	gene	gene	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	1496	1499	but	but	O	CC	O	24	DEP	O
O	O	1500	1504	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	1505	1516	interaction	interaction	B-NP	NN	O	30	SUB	O
O	O	1517	1521	with	with	B-PP	IN	O	25	NMOD	O
O	O	1522	1529	another	another	B-NP	DT	O	29	NMOD	O
T25	B-Entity	1530	1538	enhancer	enhancer	I-NP	NN	B-DNA	29	NMOD	B-DNA
T25	I-Entity	1539	1546	element	element	I-NP	NN	I-DNA	26	PMOD	I-DNA
O	O	1547	1549	is	be	B-VP	VBZ	O	24	SBAR	O
O	O	1550	1559	essential	essential	B-ADJP	JJ	O	30	PRD	O
O	O	1560	1563	for	for	B-PP	IN	O	31	AMOD	O
O	O	1564	1567	its	its	B-NP	PRP$	O	34	NMOD	O
O	O	1568	1576	activity	activity	I-NP	NN	O	32	PMOD	O
O	O	1576	1577	.	.	O	.	O	3	P	O
